ArticleLeukemia research2022

Longer-term response to SARS-CoV-2 vaccine in MPN patients: Role of ruxolitinib and disease severity.

Giuseppe Auteri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.